Sydney Madrigal
Optometrist · Pembroke Pines, FLNPI 1689296196
Payments from drug & device makers
Across 182 payments — averaging $95.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$14K
- Johnson & Johnson Vision Care, Inc.$1K
- AbbVie$437
- Coopervision Inc.$200
- Bausch & Lomb Americas Inc.$171
- Biotissue Holdings Inc.$133
- plus $801 from 13 others
What the payments were for
- Consulting fees$3,62321%
- Speaking & faculty fees$5,04029%
- Travel & lodging$2,82116%
- Food & beverage$5,96134%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 87 | $14,421 |
| Johnson & Johnson Vision Care, Inc. | 44 | $1,283 |
| AbbVie(2 entities) | 16 | $437 |
| Coopervision Inc. | 7 | $200 |
| Bausch & Lomb Americas Inc. | 7 | $171 |
| Biotissue Holdings Inc. | 2 | $133 |
| Aerie Pharmaceuticals, Inc. | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 2 | $110 |
| Tarsus Pharmaceuticals, Inc. | 5 | $104 |
| Glaukos Corporation | 1 | $93 |
| Sun Pharmaceutical Industries Inc. | 1 | $93 |
| Rxsight Inc | 1 | $86 |
| Thea Pharma Inc. | 2 | $43 |
| Visionix USA, Inc | 1 | $42 |
| Dompe US, Inc. | 1 | $30 |
| Harrow Eye, LLC | 1 | $26 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
| Novartis | 1 | $15 |
| Oyster Point Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1$7,527
- Precision 1$7,525
- TOTAL30$7,421
- Precision7$4,611
- Acuvue$373
- Rhopressa$125
- Rocklatan$125
- DAILIES$102
- VUITY$101
How this compares
$17,445 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 27 | $23,989 |
| XiidraLifitegrast | 16 | $12,994 |
| MieboPerfluorohexyloctane/Pf | 11 | $7,923 |
| Brimonidine Tartrate | 16 | $1,514 |
| Latanoprost | 66 | $348 |
| Timolol Maleate | 29 | $318 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $437 | $23,98927 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $171 | $20,91727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,166 optometrist providers in Florida.
Other optometrist in Pembroke Pines
- Robert DavisPembroke Pines$217K
- Amanda NanasyPembroke Pines$190K
- Gabriela OlivaresPembroke Pines$168K
- Glenda MoheeputhPembroke Pines$160K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.